Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Employer
-
Field
-
Associate in collaboration between AstraZeneca and Queen Mary University of London (QMUL) within the domain of Artificial Intelligence for multimodal integration of multi-omics and imaging data. About the
-
Posted by Kate Stuart on Thursday, December 4, 2025 in Announcements , Job Opportunities . The AstraZeneca-University of Maryland Clinical Development Fellowship is an
-
AstraZeneca. About You We welcome applications from individuals with a wide range of backgrounds, experiences and career paths. You should be able to demonstrate: Essential Criteria: A PhD, or equivalent
-
developing the Oxford-AstraZeneca COVID-19 vaccine. With over 25 years of experience in vaccine research, the Oxford Vaccine Group undertakes vaccine research at all stages of the process, from pre-clinical
-
AstraZeneca and Newcastle University , will develop predictive models for pharmaceutical manufacturing and provide access to industrial data and high-performance computing facilities. You will gain expertise
-
, neuromuscular diseases and vaccinology. The Oxford Vaccine Group has gained international recognition for its pivotal role in vaccine development, including developing the Oxford-AstraZeneca COVID-19 vaccine
-
Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research
-
Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research
-
(R2) Application Deadline 23 Aug 2026 - 21:59 (UTC) Country Sweden Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU
-
clinical trials. The group is led by Professor Teresa Lambe OBE, a Principal Investigator on the Oxford/AstraZeneca COVID‑19 vaccine programme, who co‑designed the vaccine in January 2020, led pre‑clinical